Table 2.
Distribution and comparison of diabetes-related features among the participants.
| Features | Non-diabetic group | Diabetic group | P value |
|---|---|---|---|
| N (%) | N (%) | ||
| Previous admissions | |||
| Yes | – | 4 (6.6) | – |
| No | – | 33 (54.1) | |
| No information | – | 24 (39.3) | |
| Total | 61 (100) | ||
| Missed medications (last 1 month) | |||
| 0 doses/week | – | -38 (62.3) | – |
| 1–2 doses/week | – | -10 (16.4) | |
| 3–5 doses/week | – | -3 (4.9) | |
| > 5 doses/week | – | -1 (1.6) | |
| No information | – | -9 (14.8) | |
| Total | – | 61 (100) | |
| Insulinaemia | |||
| Hypoinsul. (< 7.6) | 7 (22.6) | 12 (20.0) | 0.57 |
| Norm. (7.6–10.6) | 7 (22.6) | 11 (18.3) | |
| Hyperinsul. (> 10.6) | 17 (54.8) | 37 (61.7) | |
| Smoking | |||
| Yes | 0 (0) | 6 (9.8) | 0.068 |
| No | 32 (100) | 55 (90.2) | |
| Total | 32 (100) | 61 (100) | |
| Visual disturbance | |||
| Yes | 8 (25) | 34 (55.7) | 0.005* |
| No | 24 (75) | 27 (44.3) | |
| Total | 32 (100) | 61 (100) | |
| Peripheral neuropathy | |||
| Yes | 1 (3.1) | 30 (49.2) | 0.001* |
| No | 31 (96.9) | 31 (50.8) | |
| Total | 32 (100) | 61 (100) | |
| Autonomic dysfunction | |||
| Yes | 0 (0) | 22 (36.1) | 0.001* |
| No | 32 (100) | 39 (63.9) | |
| Total | 32 (100) | 61 (100) | |
| Foot ulcers | |||
| Yes | 0 (0) | 2 (3.3) | 0.303 |
| No | 32 (100) | 59 (96.7) | |
| Total | 32 (100) | 61 (100) | |
| Previous coma | |||
| Yes | 0 (0) | 2 (3.3) | 0.303 |
| No | 32 (100) | 59 (96.7) | |
| Total | 32 (100) | 61 (100) | |
| Previous stroke | |||
| Yes | 0 (0) | 0 (0) | 1.0 |
| No | 32 (100) | 61 (100) | |
| Total | 32 (100) | 61 (100) | |
| Renal disease | |||
| Yes | 0 (0) | 0 (0) | 1.0 |
| No | 32 (100) | 61 (100) | |
| Total | 32 (100) | 61 (100) | |
*
Statistically significant difference (P < 0.05) between groups (Chi square test of association).